Illumina to buy DNA-sequencing competitor for $1.2 billion

Friday, November 9, 2018 - 08:30 in Mathematics & Economics

Acquisition will add Pacific Biosciences’ long-read sequencing capabilities to Illumina’s portfolio

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net